Shandong Sito Bio-technology Co Ltd 300583.SZ

Last Updated: May 15, 12:00 AM·SZSE

Shandong Sito Bio-technology Co Ltd

Shandong Sito Bio-technology Co Ltd. Stock Analysis 300583.SZ

China Health Care Small Cap
Shandong Sito Bio-technology Co., Ltd. provides steroidal pharmaceutical raw materials using biotechnology. The company is headquartered in Heze, Shandong. The company went IPO on 2017-01-06. The firm operates three product segments. The Steroid Raw Materials segment is engaged in the manufacturing of steroid raw materials using genetic engineering technology and microbial transformation technology, such as androstenedione, androstenedione, 9-hydroxyandrostenedione, hydroxyprogesterone and so on. The firm also operates Steroidal Finished Drug segment and Non-Steroidal Finished Drug segment through its subsidiary.
Read More
Lock image
crown-icon

Shariah Compliance Report

An extensive business and financial screening of the company which specifies why a stock is halal or haram!

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.